Skip to content
DataLookout
Menu

NCT06295861

Prospective Cohort Study of Panvascular Disease in China(PAN-China)

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Enrollment reopened Show 6 more changesShow less
    • Eligibility criteria expanded, about 129 words
    • Trial arms changed: 2 → 3
    • Study sites: 2 to 3
    • Study description expanded, about 486 words
    • Collaborators expanded, about 80 words
    • Study title expanded, about 2 words
  2. Notable Changed Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University to Second Affiliated Hospital, Zhejiang University, School of Medicine
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Cardiovascular adverse events
Timeframe: 1, 3, and 5 years follow-up
Cardiovascular mortality
Timeframe: 1, 3, and 5 years follow-up

Secondary (2)

Rate of receiving vascular revascularization
Readmission rate for vascular reasons

Arms and interventions

Patients with panvascular disease cohort

The patient had atherosclerosis in 2 or more vessels

Patients with single disease cohort

The patient had atherosclerosis in 1 vessel

High risk cohort

individuals at high risk of ASCVD or suffering from metabolic syndrome

Other: no different intervention between the two cohort.

Sites

3 sites in 1 country